• Теги
    • избранные теги
    • Компании1866
      • Показать ещё
      Разное601
      • Показать ещё
      Международные организации51
      • Показать ещё
      Страны / Регионы539
      • Показать ещё
      Формат40
      Издания64
      • Показать ещё
      Люди107
      • Показать ещё
      Показатели40
      • Показать ещё
17 февраля, 23:34

Mylan's Proposed Biosimailar for Cancer Under Review in U.S.

Mylan N.V. (MYL) and Biocon Ltd. announced that the FDA has accepted their biologics license application for a biosimilar version of Amgen's (AMGN) Neulasta (pegfilgrastim) - MYL-1401H.

13 февраля, 21:13

The Story Of The Suicide Of A Powerful Lobbyist Threatens To Rock K Street

WASHINGTON ― On Thursday, July 9, 2015, Evan Morris, a super lobbyist with the biotech firm Genentech ― one of the largest pharmaceutical companies in the world ― texted with his wife, the mother of their two children, and headed to the exclusive Robert Trent Jones Golf Club in Virginia, an elite club and course that hosts major tournaments and has been played by former President Barack Obama and Tiger Woods. Morris bought the bar a round of drinks, running up an eye-popping tab. He then walked out to the club’s fire pit overlooking the lake. His wife, who had gotten an inkling of what he was about to do, frantically pleaded with him, texting him photos of their children. He shot himself in the head. Local police and fire departments both say that they were dispatched to the scene just after 10 p.m. Four days later, a statement from Genentech appeared in Politico Influence, a newsletter targeting K Street. “We are deeply saddened by the passing ... During his time with Genentech and Roche, Evan made many important contributions to the company in support of the patients we serve,” the firm said, referring to Swiss pharmaceutical giant Hoffmann-La Roche, Genentech’s parent company. “Our thoughts are with Evan’s family and we ask that you respect their privacy at this time.” The funeral had been held the day before. Washington, at least publicly, has respected the family’s privacy: Despite the fact that Morris, who was just 38, was one of the top lobbyists in the city ― he was the head of all government affairs at Genentech ― his death, until Monday, had not been mentioned beyond the blurb in the K Street newsletter and a one-line obituary on the website of the Jefferson Funeral Chapel that reads: “Resided in Alexandria, VA.” His life has largely been scraped from the internet and social media. That changed when The Wall Street Journal’s Brody Mullins published an expose into what it describes as an affair that is “shaping up to be one of the biggest U.S. investigations into Washington’s influence business since the bribery and corruption case surrounding lobbyist Jack Abramoff rocked the nation’s capital in the mid-2000s.”  Genentech, for its part, continued to dig after Morris died. Prior to his death, the drug company had been probing what it identified as spending irregularities coming out of the Washington office Morris ran, according to people briefed by the firm on the investigation. Morris learned of the probe the week he died; that probe continued after his death, focusing on consulting firms that Morris directed money toward, the sources said. The company had noticed an unusually high amount of spending on Washington consultants, the sources said, and had questions about whether Morris was taking illicit payments in exchange for doling out contracts, or whether he himself was in control of some of the accounts where money was going. Shortly after his death, The Huffington Post began investigating the circumstances surrounding it. In September 2015 and again in February 2016, a spokesman for Genentech declined to confirm or deny the allegations, citing personnel policy. On Monday, HuffPost reached back out in the wake of the Journal story and got a new statement. We expect our employees at every level of the organization to operate with integrity, consistent with the law and with our internal policies and training. In 2015 an internal investigation concluded that a senior vice president of the company had violated our policies and procedures, created schemes to misappropriate company funds for personal gain, and deliberately concealed his actions. Based on information from our investigation, we immediately suspended the employee and began efforts to recover the misappropriated funds. Although we believe this was an isolated situation, we have put additional measures and controls in place to further protect against this type of misconduct in the future. We remain deeply disappointed and saddened by these events. In every industry where companies compete for contracts, there is always the temptation for those making the bids to offer to share some of the contract with the person making the decision. The ancient transaction is known as a kickback. In Washington, it’s customary for consultants to lavish financial decision-makers with dinners, and private boxes at concerts and ballgames, but cash payments are considered inappropriate.   “Genentech has told its consultants that they are not to speak to any reporters and that if they hear from any they should tell the reporter to call Genentech,” said one source whose firm does business with the company and was on the receiving end of Genentech inquiries about payments.  While sources told HuffPost that the Genentech investigation had found evidence of kickbacks, the Journal was able to review financial documents showing the flow of money from Genentech to clients, and then from clients back to Morris’ personal bank account.  According to lobbying disclosure records on file with the Senate, Genentech has cut ties with at least one lobbying firm ― CM Government Relations ― since Morris’ death. Public relations firms ― known in Washington as shadow lobbying organizations ― do not need to file public disclosure forms, so only the official lobbying firms could be tracked. An official at CM Government Relations referred HuffPost to Genentech for comment. “As part of our standard business practices, we regularly evaluate our engagements with lobbyists and consultants,” a Genentech spokesperson told HuffPost in April 2016. “Currently, we are not working with CM Government Relations.” Morris previously said his work with the pharmaceutical industry was inspired by his mother’s battle with cancer, and he became a major player in the Washington power scene. Beyond his family home purchased for $1.7 million in northern Virginia, he owned a condo in the exclusive Millennium Tower in San Francisco, where units go from $1 million to $9 million, and, until 2013, a home on the water on the Eastern Shore that he purchased for $3.1 million. A K Street source who dined with him ― for lunch ― at the lobbyist-favorite Tosca in the months before he died remembers him ordering a bottle of wine so expensive that the owner insisted on coming by the table to sample it. “He was at the top of the food chain,” he said of Morris. Morris was a wine aficionado who could hang with some of the biggest spenders in the game. He chaired the 2015 Heart’s Delight wine tasting and auction for charity, a multiday affair of wine drinking and wine buying in Washington. That he could chair such an event at such a young age spoke not just to his wealth and lifestyle, but his meteoric rise. @VictorAlbisu and sponsor Evan Morris of Genentech at an early #heartsdelight Private Dinner at Del Campo! pic.twitter.com/aSuEi3Fuq6— Heart's Delight (@heartsdelight) January 21, 2014 He was also on the board of trustees of the James Beard Foundation, the kingmakers of the food world; New York Mayor Bill de Blasio put him on the committee, whose aim was to bring the Democratic National Convention to the city. (It lost to Philadelphia.) In 2009, Genentech and Morris found themselves in the news when The New York Times reported that 12 members of Congress entered remarks into the Congressional Record that were written by Genentech’s lobbyists. Many of the members who reprinted Genentech’s statements as their own also received contributions from the company’s PAC and employees. Morris told the Times, “There was no connection between the contributions and the statements.”  Morris’ neighbors, like his colleagues on K Street, were stunned by the news of his death. The night before his suicide, Morris had held a big Democratic Party fundraiser at his home in his Alexandria, Virginia, neighborhood, where Gov. Terry McAuliffe stayed till late in the evening. The street leading to their house was lined with cars. A Democratic Party flag flew from their front porch. A relative who answered the phone at Morris’ house said the family would decline comment for this story. “We love him and we miss him,” his father said when reached in New York, declining to comment further. Morris had gotten his start in D.C. at 18 as a gopher in the Clinton White House. He told one trade publication that “he learned a lasting lesson from his boss, the deputy chief of staff.” “Speak truth to power, no matter how powerful the individual or how ugly the truth,” he recalled the deputy chief of staff telling him. “At the end of the day, that’s how I want to be known.” Jason Cherkis contributed reporting.  If you or someone you know needs help, call 1-800-273-8255 for the National Suicide Prevention Lifeline. You can also text HELLO to 741-741 for free, 24-hour support from the Crisis Text Line. Outside of the U.S., please visit the International Association for Suicide Prevention for a database of resources. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.

13 февраля, 21:13

The Story Of The Suicide Of A Powerful Lobbyist Threatens To Rock K Street

WASHINGTON ― On Thursday, July 9, 2015, Evan Morris, a super lobbyist with the biotech firm Genentech ― one of the largest pharmaceutical companies in the world ― texted with his wife, the mother of their two children, and headed to the exclusive Robert Trent Jones Golf Club in Virginia, an elite club and course that hosts major tournaments and has been played by former President Barack Obama and Tiger Woods. Morris bought the bar a round of drinks, running up an eye-popping tab. He then walked out to the club’s fire pit overlooking the lake. His wife, who had gotten an inkling of what he was about to do, frantically pleaded with him, texting him photos of their children. He shot himself in the head. Local police and fire departments both say that they were dispatched to the scene just after 10 p.m. Four days later, a statement from Genentech appeared in Politico Influence, a newsletter targeting K Street. “We are deeply saddened by the passing ... During his time with Genentech and Roche, Evan made many important contributions to the company in support of the patients we serve,” the firm said, referring to Swiss pharmaceutical giant Hoffmann-La Roche, Genentech’s parent company. “Our thoughts are with Evan’s family and we ask that you respect their privacy at this time.” The funeral had been held the day before. Washington, at least publicly, has respected the family’s privacy: Despite the fact that Morris, who was just 38, was one of the top lobbyists in the city ― he was the head of all government affairs at Genentech ― his death, until Monday, had not been mentioned beyond the blurb in the K Street newsletter and a one-line obituary on the website of the Jefferson Funeral Chapel that reads: “Resided in Alexandria, VA.” His life has largely been scraped from the internet and social media. That changed when The Wall Street Journal’s Brody Mullins published an expose into what it describes as an affair that is “shaping up to be one of the biggest U.S. investigations into Washington’s influence business since the bribery and corruption case surrounding lobbyist Jack Abramoff rocked the nation’s capital in the mid-2000s.”  Genentech, for its part, continued to dig after Morris died. Prior to his death, the drug company had been probing what it identified as spending irregularities coming out of the Washington office Morris ran, according to people briefed by the firm on the investigation. Morris learned of the probe the week he died; that probe continued after his death, focusing on consulting firms that Morris directed money toward, the sources said. The company had noticed an unusually high amount of spending on Washington consultants, the sources said, and had questions about whether Morris was taking illicit payments in exchange for doling out contracts, or whether he himself was in control of some of the accounts where money was going. Shortly after his death, The Huffington Post began investigating the circumstances surrounding it. In September 2015 and again in February 2016, a spokesman for Genentech declined to confirm or deny the allegations, citing personnel policy. On Monday, HuffPost reached back out in the wake of the Journal story and got a new statement. We expect our employees at every level of the organization to operate with integrity, consistent with the law and with our internal policies and training. In 2015 an internal investigation concluded that a senior vice president of the company had violated our policies and procedures, created schemes to misappropriate company funds for personal gain, and deliberately concealed his actions. Based on information from our investigation, we immediately suspended the employee and began efforts to recover the misappropriated funds. Although we believe this was an isolated situation, we have put additional measures and controls in place to further protect against this type of misconduct in the future. We remain deeply disappointed and saddened by these events. In every industry where companies compete for contracts, there is always the temptation for those making the bids to offer to share some of the contract with the person making the decision. The ancient transaction is known as a kickback. In Washington, it’s customary for consultants to lavish financial decision-makers with dinners, and private boxes at concerts and ballgames, but cash payments are considered inappropriate.   “Genentech has told its consultants that they are not to speak to any reporters and that if they hear from any they should tell the reporter to call Genentech,” said one source whose firm does business with the company and was on the receiving end of Genentech inquiries about payments.  While sources told HuffPost that the Genentech investigation had found evidence of kickbacks, the Journal was able to review financial documents showing the flow of money from Genentech to clients, and then from clients back to Morris’ personal bank account.  According to lobbying disclosure records on file with the Senate, Genentech has cut ties with at least one lobbying firm ― CM Government Relations ― since Morris’ death. Public relations firms ― known in Washington as shadow lobbying organizations ― do not need to file public disclosure forms, so only the official lobbying firms could be tracked. An official at CM Government Relations referred HuffPost to Genentech for comment. “As part of our standard business practices, we regularly evaluate our engagements with lobbyists and consultants,” a Genentech spokesperson told HuffPost in April 2016. “Currently, we are not working with CM Government Relations.” Morris previously said his work with the pharmaceutical industry was inspired by his mother’s battle with cancer, and he became a major player in the Washington power scene. Beyond his family home purchased for $1.7 million in northern Virginia, he owned a condo in the exclusive Millennium Tower in San Francisco, where units go from $1 million to $9 million, and, until 2013, a home on the water on the Eastern Shore that he purchased for $3.1 million. A K Street source who dined with him ― for lunch ― at the lobbyist-favorite Tosca in the months before he died remembers him ordering a bottle of wine so expensive that the owner insisted on coming by the table to sample it. “He was at the top of the food chain,” he said of Morris. Morris was a wine aficionado who could hang with some of the biggest spenders in the game. He chaired the 2015 Heart’s Delight wine tasting and auction for charity, a multiday affair of wine drinking and wine buying in Washington. That he could chair such an event at such a young age spoke not just to his wealth and lifestyle, but his meteoric rise. @VictorAlbisu and sponsor Evan Morris of Genentech at an early #heartsdelight Private Dinner at Del Campo! pic.twitter.com/aSuEi3Fuq6— Heart's Delight (@heartsdelight) January 21, 2014 He was also on the board of trustees of the James Beard Foundation, the kingmakers of the food world; New York Mayor Bill de Blasio put him on the committee, whose aim was to bring the Democratic National Convention to the city. (It lost to Philadelphia.) In 2009, Genentech and Morris found themselves in the news when The New York Times reported that 12 members of Congress entered remarks into the Congressional Record that were written by Genentech’s lobbyists. Many of the members who reprinted Genentech’s statements as their own also received contributions from the company’s PAC and employees. Morris told the Times, “There was no connection between the contributions and the statements.”  Morris’ neighbors, like his colleagues on K Street, were stunned by the news of his death. The night before his suicide, Morris had held a big Democratic Party fundraiser at his home in his conservative Alexandria, Virginia, neighborhood, where Gov. Terry McAuliffe stayed till late in the evening. The street leading to their house was lined with cars. A Democratic Party flag flew from their front porch. A relative who answered the phone at Morris’ house said the family would decline comment for this story. “We love him and we miss him,” his father said when reached in New York, declining to comment further. Morris had gotten his start in D.C. at 18 as a gopher in the Clinton White House. He told one trade publication that “he learned a lasting lesson from his boss, the deputy chief of staff.” “Speak truth to power, no matter how powerful the individual or how ugly the truth,” he recalled the deputy chief of staff telling him. “At the end of the day, that’s how I want to be known.” Jason Cherkis contributed reporting.  If you or someone you know needs help, call 1-800-273-8255 for the National Suicide Prevention Lifeline. You can also text HELLO to 741-741 for free, 24-hour support from the Crisis Text Line. Outside of the U.S., please visit the International Association for Suicide Prevention for a database of resources. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.

Выбор редакции
11 февраля, 11:00

Beauty: the best heavy-duty hand creams | Sali Hughes

I apply plenty before bed and, if nothing more interesting is happening, pop cotton socks over my hands and incubate overnightI have had dozens of emails in the last two months about dry, cracked, even bleeding hands. I can think of no reason why this winter should be worse than any other, but the in-out-in cycle of bitter cold and central heating always plays havoc with hands to the point where one can feel pretty miserable about their appearance and discomfort.In harsh conditions, a regular hand cream barely touches the sides, so it’s necessary to up the ante to a more hardcore preparation. I have long-standing favourites for the job – Hand Chemistry Heel Hydration Complex (£12.74) and La Roche-Posay’s Cicaplast Hands (£4.33) are my go-tos when extreme measures are required – but I’m always intrigued by lesser-known products I’ve yet to try. Continue reading...

09 февраля, 00:16

Can Prothena (PRTA) Pull a Surprise This Earnings Season?

Prothena Corporation plc (PRTA) is scheduled to report fourth-quarter 2016 results on Feb 14 after the market closes.

08 февраля, 18:26

А вы за нас еще и лечить будете? Роботы в белых халатах

Как можно использовать искуственный интеллект для лечения и диагностики различных заболеваний

Выбор редакции
08 февраля, 17:57

Allergan (AGN) Tops Q4 Earnings; 2017 Sales View Upbeat

Allergan plc's (AGN) fourth-quarter 2016 earnings came in at $3.90 per share, beating the Zacks Consensus Estimate of $3.79 by 2.9%.

06 февраля, 11:36

What posterity has done for us

Sir Boyle Roche famously said, "Why we should put ourselves out of our way to do anything for posterity, for what has posterity ever done for us?" Quite a lot, actually. We were born into a culture that took generations to create. The people who came before us built a civil society, invented a language, created a surplus, enabling us to each grow up without contributing much at all for the first 15 years of our life. Posterity, as created by the folks that came before, solved countless problems so we could work on the problems that lie ahead. Posterity gave us jazz, the scientific method and medicine. It gave us a stable platform to connect, to invent and to produce. We are someone else's posterity. Each of us is here, and is able to do what we do, because others did something for posterity. In many ways, our contributions to each other and our culture are a tiny repayment of our huge debt to people we'll never get to meet. People who sacrificed and stood up for posterity. Otherwise known as us. I've never met anyone who honestly felt that they would have been better off living at the beginning of any century other than this one. And our job is to build the foundations necessary for our great grandchildren to feel the same way about the world they're born in. It's only fair, isn't it?        

04 февраля, 01:28

Bristol-Myers' Injectable Opdivo Gets FDA Approval for mUC

Bristol-Myers Squibb Company (BMY) announced that the FDA has approved an injectable form of immuno-oncology drug Opdivo

02 февраля, 20:42

Maggie Roche obituary

Singer who brought alto harmonies and quirky songwriting to the folk-pop family trio the RochesMaggie Roche, who has died aged 65, was the eldest of the trio of singing sisters the Roches, whose songs bridged the gap between American folk and pop styles. Maggie brought her low alto voice to the harmonies she wove with her sisters, Terre and Suzzy, in her quirky, often funny but always heartfelt songs.Maggie received her first big break when she and Terre attended a songwriting course led by Paul Simon at New York University in 1970. The experience gave the two sisters added confidence to write and perform, and when looking for a record company they contacted Simon, who used them as backing singers on his 1973 album There Goes Rhymin’ Simon, paid for their music lessons and then helped produce their duo album, Seductive Reasoning (1975). Though Simon recognised their talent, the experience overwhelmed the two sisters, who disappeared for six months to study martial arts. Upon their return, they were joined by Suzzy, performing as a trio at Gerde’s Folk City and elsewhere in Greenwich Village, New York. Continue reading...

02 февраля, 18:54

Roche (RHHBY) Beats on Earnings in 2016, Misses on Sales

Roche beat on earnings but missed on sales in 2016 due to decline in sales of Lucentis, Pegasys, Avastin and Tarceva.

02 февраля, 10:35

Рынки акций Европы выросли в среду на отчетности компаний и статданных КНР, еврозоны

Фондовые индексы стран Западной Европы выросли в среду на статданных из Китая и еврозоны, а также отчетности крупных компаний.

02 февраля, 00:09

«Великое снотворное». Что читатели разных стран думают об «Улиссе» Джойса

2 февраля 135 лет назад на свет появился ирландский писатель и поэт Джеймс Джойс, автор одного из самых сложных и в то же время популярных романов в истории мировой литературы — «Улисс».

Выбор редакции
01 февраля, 18:19

Годовая прибыль Roche Holding поднялась на 8% г/г

Швейцарская фармацевтическая компания Roche Holding заявила о том, что чистая прибыль (причитающаяся акционерам) увеличилась в 2016 году на 8% г/г и составила 9,6 млрд швейцарских франков ($9,7 млрд). Выручка, тем временем, поднялась на 5% г/г и достигла 50,6 млрд франков. Заметим, что аналитики прогнозировали прибыль на уровне 10,7 млрд франков при выручке в 50,7 млрд франков.

01 февраля, 15:50

SanofiRegeneron Sarilumab Approved in Canada for Arthritis

Sanofi (SNY) and Regeneron Pharmaceuticals, Inc. (REGN) announced that their pipeline candidate, sarilumab, has been approved in Canada for the treatment of adult patients with moderate-to-severely active rheumatoid arthritis (RA).

Выбор редакции
01 февраля, 15:32

Roche underlines ‘value’ of drugmakers to the US

Comments come as Swiss drugmaker reports 4% increase in group sales

Выбор редакции
01 февраля, 14:30

Основные фондовые индексы Европы растут

Фондовые индексы стран Западной Европы повышаются, инвесторы оценивают статданные из еврозоны и отчетность крупных компаний. Индекс менеджеров закупок (PMI) в обрабатывающей промышленности 19 стран еврозоны в январе вырос 54,9 до 55,2 пункта - самой высокой отметки почти за шесть лет. Предварительные данные указывали на повышение до 55,1 пункта. Значение индикатора выше 50 пунктов говорит об усилении деловой активности в данном секторе экономики. Индекс менеджеров по закупкам от Markit / CIPS для производственного сектора Великобритании снизился до 55,9 в январе с двух с половиной летнего максимума в декабре 56,1. Индекс был в соответствии с ожиданиями экономистов. Сводный индекс крупнейших предприятий региона Stoxx Europe 600 поднялся на 0,85% - до 363,17 пункта. Цена акций шведского производителя грузовиков Volvo AB подскочила в ходе торгов на 6,4% на данных, что компания увеличила прибыль в прошлом квартале почти в 2 раза. Рыночная стоимость Siemens AG повысилась на 3,4%. Крупнейший в Европе промышленный конгломерат увеличил чистую прибыль в 1-м квартале текущего фингода на четверть и улучшил прогноз на год в целом. Бумаги испанского банка BBVA подорожали на 0,7%. Прибыль банка в прошлом квартале упала на 28% - до 678 млн евро, что тем не менее оказалось лучше прогнозов рынка (554 млн евро). Бюджетный авиаперевозчик Wizz Air Holdings сообщил о падении чистой прибыли в прошлом квартале на 22%, несмотря на рост выручки на 9%. На этой новости котировки акций в начале торгов упали на 6,6%. Капитализация швейцарской фармкомпании Roche Holding AG поднялась на 1,1% благодаря увеличению прибыли в октябре-декабре на 8% и выручки на 5%. Шведский банк SEB AB увеличил рыночную стоимость на 2,9% благодаря повышению дивидендов за прошлый год. Эта мера компенсировала в глазах инвесторов небольшое снижение квартальной прибыли, до 4,24 млрд шведских крон ($484 млн) с 4,6 млрд крон. Цена акций производителя бытовой техники Electrolux снизилась на 1,4%. Компания вернулась на прибыльный уровень в 4-м квартале, ее прибыль составила 1,27 шведской кроны и совпала с ожиданиями рынка. Между тем ее выручка снизилась на 1%. Бумаги швейцарского банка Julius Baer подорожали на 2,5%. Банк увеличил прибыль в прошлом году более чем в 2 раза, до 706 млн франков ($713 млн), благодаря росту объема активов под управлением. На текущий момент FTSE 7150.34 51.19 0.72% DAX 11645.41 110.10 0.95% CAC 4802.53 53.63 1.13% Информационно-аналитический отдел TeleTradeИсточник: FxTeam

Выбор редакции
01 февраля, 11:25

Годовая прибыль Roche Holding поднялась на 8% г/г

Швейцарская фармацевтическая компания Roche Holding заявила о том, что чистая прибыль (причитающаяся акционерам) увеличилась в 2016 году на 8% г/г и составила 9,6 млрд швейцарских франков ($9,7 млрд). Выручка, тем временем, поднялась на 5% г/г и достигла 50,6 млрд франков. Заметим, что аналитики прогнозировали прибыль на уровне 10,7 млрд франков при выручке в 50,7 млрд франков.

Выбор редакции
01 февраля, 00:28

UPDATE 1-Roche said to consider options for Diabetes unit- Bloomberg

Jan 31 (Reuters) - Roche Holding AG is considering options for its diabetes-care business including a sale, Bloomberg reported, citing people familiar with the matter.